Canada

Apo-Semaglutide, explained

Apo-Semaglutide is Apotex's generic version of Ozempic — the same molecule, semaglutide, authorized by Health Canada on May 1, 2026 for type 2 diabetes. It was among the first generic semaglutides anywhere, thanks to a Canadian patent that lapsed years ahead of other countries.

What you actually get

A prefilled injection pen in the familiar 2 mg and 4 mg formats, designed to work much like the brand Ozempic pen. Because it's the same active drug, the dose you and your prescriber set carries over directly.

What it costs

Generic semaglutide launched at roughly a third of brand-name Ozempic's cash price — about $88 a month at Costco, and commonly $95–120 at chain pharmacies. Prices vary by pharmacy and province and change over time, so confirm with yours.

Coverage

Public plans generally cover semaglutide for type 2 diabetes with conditions, and several provinces have begun listing the generics specifically. Coverage for weight management is a separate and much narrower story. Your pharmacist can check your exact plan and whether a generic substitution applies to your prescription.

Logging it in Light Years

Pick "Semaglutide (injection)" when you set up your plan — Apo-Semaglutide is named right there. If you switch from a brand pen, your dose and history stay yours; you're changing the label on the pen, not starting over.

Sources & last reviewed 2026: Health Canada; CBC News; The Globe and Mail. General information, not medical advice, and not a recommendation to start, stop, or switch any medication.

Light Years draws this for you, quietly. Open the app or browse the other guides.